Lumexa Imaging Holdings, Inc · Q2 2026 earnings

Briefing

Lumexa Imaging reported consolidated revenues of $264.2 million and returned to net income of $2.7 million for the second quarter ended June 30, 2026.

The company achieved 5.1% year-over-year revenue growth driven by same-center advanced outpatient volume growth of 5.2% and expansion of its advanced imaging mix. Net income improved to $2.7 million from a $7.2 million loss in the prior year, while Adjusted EBITDA remained essentially flat at $56.4 million. Management reiterated full-year 2026 revenue guidance and narrowed Adjusted EBITDA guidance to $235-241 million.

• Consolidated revenues reached $264.2 million, up 5.1% from $251.4 million in Q2 2025.
• Net income of $2.7 million versus net loss of $7.2 million year-over-year; GAAP EPS $0.03 and Adjusted EPS $0.20.
• Advanced outpatient volume grew 6.8% consolidated and same-center advanced volume grew 5.2%.
• Full-year 2026 revenue guidance reiterated at $1.045-1.097 billion; Adjusted EBITDA narrowed to $235-241 million.

Headline financials

Revenue & EPS history

Full-year 2026 consolidated revenue guidance reiterated at $1.045-1.097 billion; Adjusted EBITDA narrowed to $235-241 million with midpoint unchanged at $238 million; Adjusted EPS guidance of $0.71-0.77 reiterated.